Sky Century Investment (SKYI) Assets Average (2013 - 2026)

Sky Century Investment's (SKYI) quarterly Assets Average came in at $118579.5 in Q2 2026, up 25.95% year-on-year from $94147.5 in Q2 2025, and up 6.78% on a QoQ basis from $111054.5 in Q1 2026.

Sky Century Investment (SKYI) Assets Average (2013 - 2026) Analysis & Trends

Sky Century Investment (SKYI) has 4 years of Assets Average data on file, last reported at $118579.5 in Q2 2026.

  • On a quarterly basis, Assets Average rose 25.95% year-over-year to $118579.5 in Q2 2026; TTM through May 2026 was $118579.5, a 25.95% increase from a year earlier, with the FY2025 full-year figure at $103563.0, up 115.98% from the prior year.
  • Assets Average for Q2 2026 stood at $118579.5, up from $111054.5 in the prior quarter.
  • Over the last five years, Assets Average for SKYI reached as high as $118579.5 in Q2 2026 and fell as low as $94147.5 in Q2 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 43.72 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 40.39 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 15.32 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 99.52 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 7.30 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 68.63 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 37.01 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 4.77 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 13.29 Bn
10 Sky Century Investment 1.06 Mn 1.06 Mn 26,045.00 118,579.50

Historic Data

Download Data
DateValue
May 31, 2026 118,579.50
Feb 28, 2026 111,054.50
Nov 30, 2025 112,632.50
Aug 31, 2025 118,089.50
May 31, 2025 94,147.50
Aug 31, 2014 515.00
May 31, 2014 515.00
Feb 28, 2014 3,040.00
Nov 30, 2013 3,022.00
Aug 31, 2013 316.50